PDFs by language
Our 24/7 cancer helpline provides support for people dealing with cancer. We can connect you with trained cancer information specialists who will answer questions about a cancer diagnosis and provide guidance and a compassionate ear.
Chat live online
Select the Live Chat button at the bottom of the page
At our National Cancer Information Center trained Cancer Information Specialists can answer questions 24 hours a day, every day of the year to empower you with accurate, up-to-date information to help you make educated health decisions. We connect patients, caregivers, and family members with valuable services and resources.
Or ask us how you can get involved and support the fight against cancer. Some of the topics we can assist with include:
For medical questions, we encourage you to review our information with your doctor.
Kidney cancer is a type of cancer that starts in the kidney. Cancer starts when cells in the body begin to grow out of control. To learn more about how cancers start and spread, see What Is Cancer?
To understand kidney cancer, it helps to know about the normal structure and function of the kidneys.
The kidneys are a pair of bean-shaped organs, each about the size of a fist. They are attached to the upper back wall of the abdomen and protected by the lower rib cage. One kidney is just to the left and the other just to the right of the backbone. The upper and lower portions of each kidney are sometimes called the superior pole and inferior pole.
A small organ called an adrenal gland sits on top of each kidney. Each kidney and adrenal gland is surrounded by fat and a thin, fibrous layer known as Gerota’s fascia.
The kidneys’ main job is to remove excess water, salt, and waste products from blood coming in from the renal arteries. These substances become urine. Urine collects in the center of each kidney in an area called the renal pelvis and then leaves the kidneys through long slender tubes called ureters. The ureters lead to the bladder, where the urine is stored until you urinate.
The kidneys also have other jobs:
Our kidneys are important, but we can function with only one kidney. Many people in the United States are living normal, healthy lives with just one kidney.
Some people do not have working kidneys at all, and survive with the help of a medical procedure called dialysis. The most common form of dialysis uses a specially designed machine that filters blood much like a real kidney would.
Renal cell carcinoma (RCC), also known as renal cell cancer or renal cell adenocarcinoma, is the most common type of kidney cancer. About 9 out of 10 kidney cancers are renal cell carcinomas.
Although RCC usually grows as a single tumor within a kidney, sometimes there are 2 or more tumors in one kidney or even tumors in both kidneys at the same time.
There are several subtypes of RCC, based mainly on how the cancer cells look in the lab. Knowing the subtype of RCC can be a factor in deciding treatment and can also help your doctor determine if your cancer might be caused by an inherited genetic syndrome. See Risk Factors for Kidney Cancer for more information about inherited kidney cancer syndromes.
This is the most common form of renal cell carcinoma. About 7 out of 10 people with RCC have this kind of cancer. When seen in the lab, the cells that make up clear cell RCC look very pale or clear.
Papillary renal cell carcinoma: This is the second most common subtype – about 1 in 10 RCCs are of this type. These cancers form little finger-like projections (called papillae) in some, if not most, of the tumor. Some doctors call these cancers chromophilic because the cells take in certain dyes and look pink when looked at under the microscope.
Chromophobe renal cell carcinoma: This subtype accounts for about 5% (5 cases in 100) of RCCs. The cells of these cancers are also pale, like the clear cells, but are much larger and have certain other features that can be recognized when looked at very closely.
Rare types of renal cell carcinoma: These subtypes are very rare, each making up less than 1% of RCCs:
Unclassified renal cell carcinoma: Rarely, renal cell cancers are labeled as unclassified because the way they look doesn’t fit into any of the other categories or because there is more than one type of cancer cell present.
Other types of kidney cancers include transitional cell carcinomas, Wilms tumors, and renal sarcomas.
Transitional cell carcinoma: Of every 100 cancers in the kidney, about 5 to 10 are transitional cell carcinomas (TCCs), also known as urothelial carcinomas.
Transitional cell carcinomas don’t start in the kidney itself, but in the lining of the renal pelvis (where the ureters meet the kidneys). This lining is made up of cells called transitional cells that look like the cells that line the ureters and bladder. Cancers that develop from these cells look like other urothelial carcinomas, such as bladder cancer, when looked at closely in the lab. Like bladder cancer, these cancers are often linked to cigarette smoking and being exposed to certain cancer-causing chemicals in the workplace.
People with TCC often have the same signs and symptoms as people with renal cell cancer − blood in the urine and, sometimes, back pain.
For more information about transitional cell carcinoma, see Bladder Cancer.
Wilms tumor (nephroblastoma): Wilms tumors almost always occur in children. This type of cancer is very rare among adults. To learn more about this type of cancer, see Wilms Tumor.
Renal sarcoma: Renal sarcomas are a rare type of kidney cancer that begin in the blood vessels or connective tissue of the kidney. They make up less than 1% of all kidney cancers.
Sarcomas are discussed in more detail in Sarcoma- Adult Soft Tissue Cancer.
Some kidney tumors are benign (non-cancer). This means they do not metastasize (spread) to other parts of the body, although they can still grow and cause problems.
Benign kidney tumors can be treated by removing or destroying them, using many of the same treatments that are also used for kidney cancers, such as surgery or radiofrequency ablation. The choice of treatment depends on many factors, such as the size of the tumor and if it is causing any symptoms, the number of tumors, whether tumors are in both kidneys, and the person’s general health.
Angiomyolipoma: Angiomyolipomas are the most common benign kidney tumor. They are seen more often in women. They can develop sporadically or in people with tuberous sclerosis, a genetic condition that also affects the heart, eyes, brain, lungs, and skin.
These tumors are made up of different types of connective tissues (blood vessels, smooth muscles, and fat). If they aren’t causing any symptoms, they can often just be watched closely. If they start causing problems (like pain or bleeding), they may need to be treated.
Oncocytoma: Oncocytomas are benign kidney tumors that are not common and can sometimes grow quite large. They are seen more often in men and do not normally spread to other organs, so surgery often cures them.
The rest of our information about kidney cancer focuses on renal cell carcinoma and not on less common types of kidney tumors.
The American Cancer Society medical and editorial content team
Our team is made up of doctors and oncology certified nurses with deep knowledge of cancer care as well as journalists, editors, and translators with extensive experience in medical writing.
Atkins MB and Choueiri TK. UpToDate. Epidemiology, pathology, and pathogenesis of renal cell carcinoma. This topic last updated: Mar 05, 2019. Accessed at https://www.uptodate.com/contents/epidemiology-pathology-and-pathogenesis-of-renal-cell-carcinoma on November 22, 2019.
Kay FU and Pedrosa I. Imaging of Solid Renal Masses. Urol Clin North Am. 2018; 45:311-330. doi: 10.1016/j.ucl.2018.03.013. Epub 2018 Jun 15.
McNamara MA, Zhang T, Harrison MR, George DJ. Ch 79 - Cancer of the kidney. In: Niederhuber JE, Armitage JO, Doroshow JH, Kastan MB, Tepper JE, eds. Abeloff’s Clinical Oncology. 6th ed. Philadelphia, Pa: Elsevier: 2020.
Last Revised: May 5, 2020
American Cancer Society medical information is copyrighted material. For reprint requests, please see our Content Usage Policy.